
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Novo Nordisk(SIGNIFICANT) OTHER FINANCIAL BENEFIT: OptumRx(MODEST)
CONSULTING FEES/HONORARIA: Novo Nordisk(SIGNIFICANT) OTHER FINANCIAL BENEFIT: OptumRx(MODEST)
© 2025 American College of Cardiology Foundation. All rights reserved.
Last Updated December 2021